GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.

Highlights Guizhou Bailing Group Pharmaceutical Co., Ltd.

Equities

002424

CNE100000PY3

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 01/07/2024 BST			5-day change	1st Jan Change
3.25 ^CNY	+1.25%		+3.50%	-59.93%

05-21	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from FTSE All-World Index	CI
05-10	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from S&P Global BMI Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Large-Scale Equipment Renewals Seen to Raise Demand for Chinese High-End Steel Products, Trade Body Says	05-03	MT
China to Tweak Production Limits for Steel as Industry Faces Low Prices, Oversupply	05-02	MT
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	04-02	CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	02-02	CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	02-01	CI
Bailing Group Pharma Gets Green Light for Clinical Trial of New Hepatitis B Drug	12-28	MT
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.	10/07/23	CI
Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 9, 2023 has closed with 12,096,900 shares, representing 0.87% for CNY 100.01 million.	06/07/23	CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.	04/07/23	CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.	03/04/23	CI
Zhejiang Futures Co., Ltd completed the acquisition of 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei.	30/03/23	CI
Zhejiang Futures Co., Ltd agreed to acquire a 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei for approximately CNY 210 million.	28/02/23	CI
Guizhou Bailing Group Pharma to Repurchase Up to 200 Million Yuan Shares	10/01/23	MT
Guizhou Bailing Group Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	09/01/23	CI
Guizhou Bailing Group Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	08/01/23	CI
Zhang Shanlin completed the acquisition of 3.83% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Yong for approximately ¥500 million.	20/12/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Guizhou Bailing Group Pharmaceutical Co., Ltd.

Equities

002424

CNE100000PY3

Highlights

Filters